Psychosis and type 2 diabetes study (PODS) - Study 1
Research type
Research Study
Full title
Developing an integrated model of care for people with severe mental illness and type 2 diabetes: the PsychOsis and Diabetes Service Model (PODS) - Study 1, profiling the population.
IRAS ID
307600
Contact name
Kirsty Winkley
Contact email
Sponsor organisation
King's College London
Duration of Study in the UK
0 years, 6 months, 2 days
Research summary
People with severe mental illness (SMI), defined as psychotic and bipolar disorders, die 17-20 years earlier than the general population, the most common cause of death being cardiovascular diseases (CVD). A major contributor to CVD mortality in SMI is the increased prevalence of type 2 diabetes (T2D). In the National Diabetes Audit 2016-17 in primary care, people with SMI and T2D were 10% less likely to take up all 9 diabetes care processes, to be prescribed diabetes medications and have worse glycaemic control as a result. Therefore, improving access to diabetes care for individuals with T2D and SMI should be a priority. Previous research has focused on upskilling mental health professionals or link workers in diabetes care, however, a primary care led focus to support individuals with T2D and SMI has not been investigated. We will profile the population of people with SMI and T2D within Lambeth and take baseline measures. This data will be used in a future study (part 2), test a new model of care for people with SMI and T2D that is led by the community DSN in collaboration with the PN and mental health team at the patient’s general practice. 10 NHS GP surgeries will be used to recruit participants, 5 from the Hills, Brooks and Dales primary care network (PCN) and 5 from the STockWELL PCN as a control group. The baseline measures that will be taken include nine questionnaires on mental health symptoms, diabetes related distress, quality of life, physical activity and alcohol and drug usage. A physical health assessment for BMI, blood pressure, urinary ACR, blood test for HbA1c, glucose test, total cholesterol and renal function. A brief interview take place to discuss where the participant would like to receive their care, and experience of digital interventions.
REC name
London - South East Research Ethics Committee
REC reference
22/LO/0031
Date of REC Opinion
19 Jan 2022
REC opinion
Unfavourable Opinion